Skip Navigation


Rheumatology Advance Access originally published online on January 25, 2008
Rheumatology 2008 47(3):378-379; doi:10.1093/rheumatology/kem378
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/3/378    most recent
kem378v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cansu, D. U.
Right arrow Articles by Korkmaz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cansu, D. U.
Right arrow Articles by Korkmaz, C.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA

D. Ü. Cansu and C. Korkmaz

Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, 26480, Turkey

Correspondence to: C. KORKMAZ, Visnelik M. Alifuat Güven C. Akasya S. 11/11, 26020, Eskisehir, Turkey. E-mail: ckorkmaz@ogu.edu.tr

The first 10% of the full text of this article appears below.

SIR, Anti-malarial drugs have become one of the most commonly prescribed drugs in the treatment of many rheumatic diseases such as RA and SLE. Anti-malarials may improve glucose tolerance. Hypoglycaemia is a rare but well-recognized adverse effect of anti-malarial therapy [1–3].

Here we described a non-diabetic patient with RA who developed hypoglycaemia under hydroxychloroquine (HCQ) treatment. We also discussed the possible mechanisms of hypoglycaemia due to HCQ.

A 62-yr-old man was admitted to our hospital with symmetric polyarthritis and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?